Scarica l'app Stockscreener
199.59
0.02%
-0.03
Dopo l'orario di chiusura:
199.59
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Ligand Pharmaceuticals Inc Borsa (LGND) Ultime notizie
Allspring Global Investments Holdings LLC Has $13.65 Million Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals Incorporated (LGND) stock price, news, quote and history - Yahoo Finance UK
LGND Earning Date, Earning Analysis and Earning Prediction - intellectia.ai
Is Ligand Pharmaceuticals (LGND) Still Attractive After Doubling Over The Past Year - finance.yahoo.com
EBIT per share of Ligand Pharmaceuticals Incorporated – OTC:LGNYZ - TradingView
Insider Sell: John Kozarich Sells Shares of Ligand Pharmaceutica - GuruFocus
Insider Sell: John Kozarich Sells Shares of Ligand Pharmaceuticals Inc (LGND) - GuruFocus
Ligand Pharmaceuticals (NASDAQ:LGND) Director John Kozarich Sells 467 Shares - MarketBeat
Ligand Pharmaceuticals (NASDAQ:LGND) Insider Andrew Reardon Sells 5,000 Shares - MarketBeat
Ligand Pharmaceuticals director Kozarich sells $94k in stock - Investing.com
Planned sales: Ligand Pharmaceuticals (LGND) director trims 467 shares - Stock Titan
Ligand Pharmaceuticals CLO sells $1m in shares - Investing.com
Ligand (NASDAQ: LGND) CLO sells 5,000 shares after exercising stock options - Stock Titan
LGND Technical Analysis & Stock Price Forecast - intellectia.ai
Ligand Pharmaceuticals Incorpor (LGND) Stock Forecasts - finance.yahoo.com
Board member Todd Davis (PTHS) updates Pelthos stock grants and holdings - Stock Titan
LGND (NASDAQ: LGND) Rule 144 sales — 467 shares on three dates - Stock Titan
Insider Move: John L LaMattina Exercises Options, Realizing $185K At Ligand Pharmaceuticals - Benzinga
Ligand Pharmaceuticals (NASDAQ:LGND) Passes Minervini Trend Template and Growth Screen - chartmill.com
Ligand Pharma CLO Sells $1.03M in Stock | Transaction Details & Company BackgroundNews and Statistics - IndexBox
Ligand Pharmaceuticals director LaMattina sells $433k in shares By Investing.com - Investing.com India
Ligand Pharmaceuticals director LaMattina sells $433k in shares - Investing.com
Ligand (NASDAQ: LGND) director exercises options, sells 2,161 common shares - Stock Titan
LIGAND PHARMACEUTICALS INCORPORATED (LGND) - MSN
CLO Sells LGND 5,000 Shares for $1.0 Million - AOL.com
Support Test: How correlated is Ligand Pharmaceuticals Incorporated to the S P500Market Risk Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
Q4 2025 Ligand Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Ligand (LGND) grants CFO stock options and 4,933 RSUs - Stock Titan
Ligand (NASDAQ: LGND) CLO awarded RSUs and stock options - stocktitan.net
Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know - Yahoo Finance
Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know - The Motley Fool
Vanguard (LGND) reports 0 shares after internal realignment (03/27/2026) - stocktitan.net
Ligand Pharmaceuticals Unveils Two New VPs of Investments, Business Development - Contract Pharma
Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team - marketscreener.com
Nordea Investment Management AB Has $10.19 Million Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Arecor receives $500k milestone payment from Ligand as royalty deal delivers - Yahoo Finance UK
Insider Sell: Stephen Sabba Sells Shares of Ligand Pharmaceutica - GuruFocus
Insider Selling: Ligand Pharmaceuticals (NASDAQ:LGND) Director Sells 1,000 Shares of Stock - MarketBeat
Ligand Pharmaceuticals director Sabba sells $207,872 in stock By Investing.com - Investing.com Australia
Ligand Pharmaceuticals director Sabba sells $207,872 in stock - Investing.com
Ligand Pharmaceuticals (LGND) director sells 1,000 shares, keeps stake - Stock Titan
Ligand Pharmaceuticals (LGND) Receives Updated Price Target from Citigroup | LGND Stock News - GuruFocus
Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $276.00 at Citigroup - MarketBeat
Ligand Pharmaceuticals (LGND) Receives Target Price Boost from C - GuruFocus
Congress Asset Management Co. Sells 187,248 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Stephen Sabba (NASDAQ: LGND) sells 2,034 shares for $409,851 - Stock Titan
AI Stocks: How does Ligand Pharmaceuticals Incorporated score in quality rankingsWeekly Trade Recap & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Tudor Investment Corp ET AL Takes $2.79 Billion Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals: Reliable Midcap Pharma With Perfected High Growth Business Model - Seeking Alpha
Penn Capital Management Company LLC Trims Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Acuitas Investments LLC Trims Holdings in Ligand Pharmaceuticals Incorporated $LGND - marketbeat.com
Granahan Investment Management LLC Purchases Shares of 24,962 Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Book value per share of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView
Clark Capital Management Group Inc. Acquires 11,858 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Latest LGND NewsLigand’s Third Quarter Financial Results to... - Stock Titan
Ligand Pharmaceuticals is a low-risk way to bet on biopharma growth: Analyst - MSN
Fresh Analyst Coverage Puts Ligand Pharmaceuticals (LGND) Royalty Model And Valuation In The Spotlight - simplywall.st
This Ligand Pharmaceuticals analyst begins coverage on a bullish note; here are top 4 initiations for Wednesday - MSN
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):